Capecitabine: A new oral fluoropyrimidine.
Ignoffo
R J
RJ
Clinical Professor of Pharmacy and Oncology, University of San Francisco, CA, USA.
D000284:Administration, Oral; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D000069287:Capecitabine; D002986:Clinical Trials as Topic; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D005472:Fluorouracil / Q000031:analogs & derivatives; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil